Clinical Trials List
Protocol NumberMK-0974-034
2008-03-06 - 2009-02-20
Phase III
Terminated2
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Jong-Ling Fuh Division of Neurology
- 陳韋達 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 周立平 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10-12 participants
-
Global
400 participants
